October 9, 2020

Global And India Erlotinib Hydrochloride Market Industry Analysis, Size, Share and Growth Trends 2025

Summary - A new market study, titled “Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025” has been featured on WiseGuyReports.

Summary

Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells and slows their spread in the body

ALSO READ: https://wiseguyreports.wordpress.com/2020/06/10/erlotinib-hydrochloride-market-2020-global-trends-opportunity-and-growth-analysis-forecast-by-2025/

Market Segment as follows:

By Type

25mg

100mg

150mg

By Application

Non-small Cell Lung Cancer

Pancreatic Cancer

By Company

Roche

Cipla

Mylan

Teva

OSI Pharmaceuticals

Glenmark Pharmaceuticals

Beacon Pharmaceuticals

Raichem Lifesciences

United Biotech

CJ Corporation

Vivimed Labs

Boryung Pharmaceutical

Taj Pharmaceuticals

Pharmascience

Natco Pharma

Intas Pharmaceuticals

RPG Life Sciences

Pharmascience

Schwarz Pharma

Dr. Reddy's Laboratories

Glenmark Pharmaceuticals

Chugai Pharmaceutical

DKSH

Firma Chun Cheong

Kremers Urban Pharmaceuticals

Ortat

Zuellig Pharma

The main contents of the report including:

Section 1:

Product definition, type and application, global and India market overview;

Section 2:

Global and India Market competition by company;

Section 3:

Global and India sales revenue, volume and price by type;

Section 4:

Global and India sales revenue, volume and price by application;

Section 5:

India export and import;

Section 6:

Company information, business overview, sales data and product specifications;

Section 7:

Industry chain and raw materials;

Section 8:

SWOT and Porter's Five Forces;

Section 9:

Conclusion.

FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3343476-global-and-india-erlotinib-hydrochloride-market-research-by

About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:

NORAH TRENT

[email protected]

Ph: +162-825-80070 (US)

Ph: +44 203 500 2763 (UK)